SCHEMBL22985392

SCHEMBL22985392

N#Cc1cc(C(F)(F)F)ccc1-c1ccc(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)c(-c2c(C#N)cccc2-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
XDH P47989 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
PTPN5 P54829 2/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
KDM4E B2RXH2 2/20 0.32
AR P10275 1/20 0.32
SSTR2 P30874 1/20 0.32
KIF11 P52732 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985387 0.97 ALOX5AP (0.37) ALOX5APFEN1XDHSMN1; SMN2ALDH1A1
SCHEMBL22985221 0.94 ALOX5AP (0.40) ALOX5APFEN1XDHSMN1; SMN2ALDH1A1
SCHEMBL22985668 0.94 KIF11 (0.38) ALOX5APFEN1XDHSMN1; SMN2GABRA1
SCHEMBL21399247 0.93 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1MAPTTDP1PTPN5
SCHEMBL22985629 0.93 ALOX5AP (0.41) ALOX5APFEN1XDHSMN1; SMN2GABRA1
SCHEMBL22985546 0.93 AR (0.38) ALOX5APFEN1XDHSMN1; SMN2MAPT
SCHEMBL20849116 0.93 AR (0.37) ALOX5APFEN1XDHSMN1; SMN2ALDH1A1
SCHEMBL22985550 0.93 ALOX5AP (0.39) ALOX5APFEN1XDHSMN1; SMN2ALDH1A1
SCHEMBL22985670 0.92 ALOX5AP (0.36) ALOX5APFEN1XDHPTPN5KIF11
SCHEMBL22985621 0.92 AR (0.42) ALOX5APFEN1XDHSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885XDH 1167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.